References
- Abdi-Ali A, Mohammadi-Mehr M, Alaei YA. 2006. Bactericidal activity of various antibiotics against biofilm-producing Pseudomonas aeruginosa. Int J Antimicrob Agents. 27:196–200.
- Agarwal G, Kapil A, Kabra SK, Das BK, Dwivedi SN. 2005. In vitro efficacy of ciprofloxacin and gentamicin against a biofilm of pseudomonas aeruginosa and its free-living forms. Natl Med J India. 18:184–186.
- Alhariri M, Azghani A, Omri A. 2013. Liposomal antibiotics for the treatment of infectious diseases. Expert Opin Drug Deliv. 10:1515–1532.
- Badrzadeh F, Rahmati-Yamchi M, Badrzadeh K, Valizadeh A, Zarghami N, Farkhani SM, Akbarzadeh A. 2016. Drug delivery and nanodetection in lung cancer. Artif Cells Nanomed Biotechnol. 44:618–634.
- Bazzi W, Sabra A, Zahreddine L, Khairallah MT, Baroud M, Hadi U, Matar GM. 2013. The inhibitory effect of micafungin on biofilm formation by pseudomonas aeruginosa. Biofouling. 29:909–915.
- Daraee H, Etemadi A, Kouhi M, Alimirzalu S, Akbarzadeh A. 2016. Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol. 44:381–391.
- Das AR, Dattagupta N, Sridhar CN, Wu WK. 2003. A novel thiocationic liposomal formulation of antisense oligonucleotides with activity against mycobacterium tuberculosis. Scand J Infect Dis. 35:168–174.
- Drulis-Kawa Z, Gubernator J, Dorotkiewicz-Jach A, Doroszkiewicz W, Kozubek A. 2006. A comparison of the in vitro antimicrobial activity of liposomes containing meropenem and gentamicin. Cell Mol Biol Lett. 11:360–375.
- Gubernator J, Drulis-Kawa Z, Dorotkiewicz-Jach A, Doroszkiewicz W, Kozubek A. 2007. In vitro antimicrobial activity of liposomes containing ciprofloxacin, meropenem and gentamicin against gram-negative clinical bacterial strains. Lett Drug Des Discov. 4:297–304.
- Halwani M, Yebio B, Suntres ZE, Alipour M, Azghani AO, Omri A. 2008. Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against pseudomonas aeruginosa. J Antimicrob Chemother. 62:1291–1297.
- Kádár B, Szász M, Kristóf K, Pesti N, Krizsán G, Szentandrássy J, et al. 2010. In vitro activity of clarithromycin in combination with other antimicrobial agents against biofilm-forming pseudomonas aeruginosa strains. Acta Microbiol Immunol Hung. 57:235–245.
- Kafil HS, Mobarez AM. 2015. Assessment of biofilm formation by enterococci isolates from urinary tract infections with different virulence profiles. J King Saud Univ Sci. 27:312–317.
- Kawamura-Sato K, Iinuma Y, Hasegawa T, Horii T, Yamashino T, Ohta M. 2000. Effect of subinhibitory concentrations of macrolides on expression of flagellin in pseudomonas aeruginosa and Proteus mirabilis. Antimicrob Agents Chemother 44:2869–2872.
- Lister PD, Wolter DJ, Hanson ND. 2009. Antibacterial-resistant pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev. 22:582–610.
- Mugabe C, Azghani AO, Omri A. 2006. Preparation and characterization of dehydration–rehydration vesicles loaded with aminoglycoside and macrolide antibiotics. Int J Pharm. 307:244–250.
- Smith AW. 2005. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? Adv Drug Deliv Rev. 57:1539–1550.
- Wikler MA. Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement. 2008: Clinical and Laboratory Standards Institute (CLSI).
- Wozniak DJ, Keyser R. 2004. Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa. Chest J. 125:62S–69S.